SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 102 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,000 | -50.0% | 2,010 | -44.4% | 0.00% | – |
| Q1 2022 | $4,000 | -92.6% | 3,616 | -78.1% | 0.00% | – |
| Q4 2021 | $54,000 | +25.6% | 16,526 | +70.3% | 0.00% | – |
| Q3 2021 | $43,000 | +22.9% | 9,702 | +49.5% | 0.00% | – |
| Q2 2021 | $35,000 | +9.4% | 6,489 | +50.9% | 0.00% | – |
| Q1 2021 | $32,000 | -97.7% | 4,301 | -96.7% | 0.00% | -100.0% |
| Q4 2020 | $1,400,000 | +2313.8% | 129,003 | +1873.4% | 0.00% | – |
| Q3 2020 | $58,000 | -92.3% | 6,537 | -90.7% | 0.00% | -100.0% |
| Q2 2020 | $752,000 | +902.7% | 70,502 | +458.3% | 0.00% | – |
| Q1 2020 | $75,000 | +5.6% | 12,627 | +23.4% | 0.00% | – |
| Q4 2019 | $71,000 | +82.1% | 10,236 | +175.0% | 0.00% | – |
| Q3 2019 | $39,000 | -60.6% | 3,722 | -65.2% | 0.00% | – |
| Q2 2019 | $99,000 | +45.6% | 10,694 | +45.2% | 0.00% | – |
| Q1 2019 | $68,000 | +88.9% | 7,367 | +13.5% | 0.00% | – |
| Q4 2018 | $36,000 | -56.6% | 6,489 | -6.6% | 0.00% | – |
| Q3 2018 | $83,000 | +232.0% | 6,948 | +260.7% | 0.00% | – |
| Q1 2018 | $25,000 | +1150.0% | 1,926 | +867.8% | 0.00% | – |
| Q4 2017 | $2,000 | +100.0% | 199 | +139.8% | 0.00% | – |
| Q2 2017 | $1,000 | -50.0% | 83 | -33.1% | 0.00% | – |
| Q1 2017 | $2,000 | -60.0% | 124 | -67.5% | 0.00% | – |
| Q3 2016 | $5,000 | – | 381 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 3,139,895 | $23,486,000 | 4.50% |
| Samsara BioCapital, LLC | 2,189,199 | $14,769,000 | 2.72% |
| Bain Capital Life Sciences Investors, LLC | 5,785,036 | $43,272,000 | 2.45% |
| Omega Fund Management, LLC | 1,562,500 | $11,688,000 | 1.11% |
| Flagship Pioneering Inc. | 2,938,494 | $21,980,000 | 0.35% |
| EcoR1 Capital, LLC | 1,000,000 | $7,480,000 | 0.33% |
| Altium Capital Management LP | 126,702 | $948,000 | 0.26% |
| Nikko Asset Management Americas, Inc. | 5,042,009 | $37,714,000 | 0.18% |
| Artal Group S.A. | 1,025,000 | $7,667,000 | 0.14% |
| Orbimed Advisors | 1,837,500 | $13,745,000 | 0.13% |